BFM 89.9

Podcast  >  Morning Run  >  Morning Brief  >  Can IP Waivers Resolve Vaccine Inequity?

Can IP Waivers Resolve Vaccine Inequity?

Dr. Lindsay Newman, Director of Economics & Country Risk, IHS Markit

11-May-21 07:30

Can IP Waivers Resolve Vaccine Inequity?

With glaring inequities in the supply and distribution of vaccines, the Biden administration has backed a plan to waive intellectual property rights for Covid-19 vaccines and treatments. We speak to Dr. Lindsay Newman, Director of Economics & Country Risk from IHS Markit on whether this could provide a solution to help end the pandemic.

Image Credit: Shutterstock.com

Produced by: Shazana Mokhtar

Presented by: Khoo Hsu Chuang, Philip See


Download the BFM mobile app. Stay at home and stay up-to-date.

Tags:  vaccineintellectual propertywaiverpandemicGovernment/Regulatory/Policy MakingHealthcare, Pharma, BiotechEconomy, MarketsBusiness AnalysisTrends and ForecastsMarketsPoliticslaw & legal mattersHealth PolicyDiseases & ConditionsMental HealthHealthy LivingFitnessScienceInvestments


Business
Money
Dan Lain-Lain

Share this podcast




Play / Pause

Listen now :

Today’s Shows